NCT05630326View on ClinicalTrials.gov

Association Between COVID-19 and UTIs Caused by ESBL Organism in Infants

CompletedOBSERVATIONAL
Enrollment

5,600

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

July 1, 2023

Study Completion Date

July 20, 2023

Conditions
Renal Insufficiency
Interventions
OTHER

comparing, prevalence

Comparing infants with UTIs caused by ESBL organism, or non ESBL organism.

OTHER

assessment

comparing infants with UTIs caused by ESBL organism, or non ESBL organism.

OTHER

association

comparing ESBLUTI with COVID-19 and ESBL UTI without COVID-19

OTHER

evaluation

comparing ESBLUTI with COVID-19 and ESBL UTI without COVID-19

Trial Locations (1)

Unknown

Hamad Medical Corporation, Doha

Sponsors
All Listed Sponsors
lead

Hamad Medical Corporation

INDUSTRY

NCT05630326 - Association Between COVID-19 and UTIs Caused by ESBL Organism in Infants | Biotech Hunter | Biotech Hunter